Back to Search Start Over

Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue

Authors :
Yannick Dieudonné
Beatrice Uring-Lambert
Mohamed Maxime Jeljeli
Vincent Gies
Yves Alembik
Anne-Sophie Korganow
Aurélien Guffroy
Immunopathologie et chimie thérapeutique (ICT)
Centre National de la Recherche Scientifique (CNRS)-Institut de biologie moléculaire et cellulaire (IBMC)
Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)
Immuno-Rhumatologie Moléculaire
Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Frontiers in Immunology, Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.00840⟩, Frontiers in Immunology, Vol 11 (2020)
Publication Year :
2020
Publisher :
HAL CCSD, 2020.

Abstract

Children with Down syndrome (DS) suffer from recurrent respiratory infections, which represent the leading cause of mortality during childhood. This susceptibility to infections is usually considered multifactorial and related to both impaired immune function and non-immunological factors. Infections are also one of the top causes of death in DS at adulthood. DS is considered an immunodeficiency with syndromic features by some researchers because of this high rate of infection and the immunological characteristics observed in children with DS. Little is known about the immune status of adult patients. Herein, we report the clinical and immune phenotype of 44 adults with DS, correlated with their infectious history. We observed that these adults had an aberrant lymphocyte phenotype with decreased naïve/memory T cell ratios and reduced numbers of switched memory B cells. The lower incidence of infectious events at adulthood distinguish DS from other inborn errors of immunity. Primary immunodeficiency-related features in DS could explain the increased risk of developing autoimmunity, malignancies, and infections. During adulthood, this immune dysfunction may be compensated for in mid-life, and infection-related mortality observed in older patients might be favored by multiple factors such as neurological impairment or nosocomial antigen exposure. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01663675 (August 13, 2012).

Details

Language :
English
ISSN :
16643224
Database :
OpenAIRE
Journal :
Frontiers in Immunology, Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.00840⟩, Frontiers in Immunology, Vol 11 (2020)
Accession number :
edsair.doi.dedup.....8474ec9586d3cdda83ac19048a511a42
Full Text :
https://doi.org/10.3389/fimmu.2020.00840⟩